Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -1.81% | 175.59 | 0.7% | $1405.98m | |
| PFE | Pfizer Inc. | -1.83% | 50.40 | 0.9% | $1327.23m | |
| ABBV | AbbVie, Inc. | -1.44% | 152.55 | 1.9% | $1169.95m | |
| BMY | Bristol-Myers Squibb Co. | -1.52% | 77.03 | 1.0% | $1169.89m | |
| MRK | Merck & Co., Inc. | -1.02% | 92.05 | 0.7% | $1097.17m | |
| LLY | Eli Lilly & Co. | -1.98% | 295.43 | 1.1% | $859.74m | |
| AZN | AstraZeneca Plc | -3.53% | 63.32 | 1.0% | $489.96m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.09% | 141.90 | 0.0% | $438.60m | |
| VERU | Veru, Inc. | -3.78% | 15.01 | 0.0% | $363.86m | |
| NVS | Novartis AG | -0.27% | 87.68 | 0.2% | $229.58m | |
| GSK | GlaxoSmithKline Plc | -2.42% | 43.63 | 0.2% | $222.90m | |
| HZNP | Horizon Therapeutics Plc | -4.82% | 88.42 | 5.4% | $193.67m | |
| SGEN | Seagen Inc. | -2.42% | 143.00 | 5.7% | $174.55m | |
| NVO | Novo Nordisk A/S | -2.61% | 103.56 | 0.1% | $171.61m | |
| VTRS | Viatris, Inc. | -1.74% | 11.27 | 0.0% | $153.78m |
Company Profile
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.